trichlorfon has been researched along with albendazole in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Brandt, FH; Eberhard, ML; Hightower, A; Ruiz-Tiben, E | 1 |
| Bunnag, D; Harinasuta, T; Sirisinha, S; Tawatsin, A; Vajrasthira, S | 1 |
| Drudge, JH; Lyons, ET; Tolliver, SC | 1 |
| Counsell, C; Garner, P; Gelband, H; Prasad, K; Salinas, R | 1 |
| Prasad, K; Salinas, R | 2 |
| Abba, K; Ramaratnam, S; Ranganathan, LN | 2 |
5 review(s) available for trichlorfon and albendazole
| Article | Year |
|---|---|
Treating neurocysticercosis medically: a systematic review of randomized, controlled trials.
Topics: Albendazole; Anthelmintics; Anticestodal Agents; Humans; Neurocysticercosis; Praziquantel; Randomized Controlled Trials as Topic; Tomography, X-Ray Computed; Treatment Outcome; Trichlorfon | 1999 |
Drugs for treating neurocysticercosis (tapeworm infection of the brain).
Topics: Albendazole; Anticestodal Agents; Brain Diseases; Humans; Neurocysticercosis; Praziquantel; Trichlorfon | 2000 |
WITHDRAWN: Drugs for treating neurocysticercosis (tapeworm infection of the brain).
Topics: Albendazole; Anticestodal Agents; Brain Diseases; Humans; Neurocysticercosis; Praziquantel; Trichlorfon | 2007 |
Anthelmintics for people with neurocysticercosis.
Topics: Adult; Albendazole; Anticestodal Agents; Brain Diseases; Child; Humans; Neurocysticercosis; Praziquantel; Trichlorfon | 2010 |
Anthelmintics for people with neurocysticercosis.
Topics: Adrenal Cortex Hormones; Adult; Albendazole; Anticestodal Agents; Brain Diseases; Child; Humans; Neurocysticercosis; Praziquantel; Randomized Controlled Trials as Topic; Trichlorfon | 2010 |
4 other study(ies) available for trichlorfon and albendazole
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Chemoprophylactic drug trials for treatment of dracunculiasis using the Dracunculus insignis-ferret model.
Topics: Albendazole; Analysis of Variance; Animals; Crustacea; Disease Models, Animal; Dracunculiasis; Dracunculus Nematode; Female; Ferrets; Ivermectin; Larva; Trichlorfon | 1990 |
Evaluation of selected anthelmintic compounds for activity against Opisthorchis viverrini.
Topics: Albendazole; Animals; Anthelmintics; Benzimidazoles; Benzodiazepinones; Cricetinae; Diphenylamine; Feces; Female; Isothiocyanates; Mebendazole; Mesocricetus; Opisthorchiasis; Opisthorchis; Praziquantel; Thiocyanates; Trichlorfon | 1984 |
Benzimidazole resistance of equine strongyles: critical tests of several classes of compounds against population B strongyles from 1977 to 1981.
Topics: Albendazole; Animals; Anthelmintics; Benzimidazoles; Drug Combinations; Drug Evaluation; Drug Resistance; Female; Guanidines; Horses; Male; Parasite Egg Count; Piperazine; Piperazines; Pyrantel Pamoate; Strongyle Infections, Equine; Strongyloidea; Thiabendazole; Trichlorfon | 1984 |